Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition.

Cytosolic THUMPD1 promotes breast cancer cells invasion and metastasis via the AKT-GSK3-Snail pathway. Oncotarget (2017) 0.75

Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression. Int J Mol Sci (2017) 0.75

Convergence of Wnt, beta-catenin, and cadherin pathways. Science (2004) 13.13

Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 10.04

Extrahepatic metastases of hepatocellular carcinoma. Radiology (2000) 4.82

Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. JAMA (2010) 4.71

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44

The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol (2003) 3.06

Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell (2007) 1.87

Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol (2009) 1.85

The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol (2012) 1.65

EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther (2011) 1.54

Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci (2013) 1.44

Cancer metastases: challenges and opportunities. Acta Pharm Sin B (2015) 1.22

NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res (2009) 1.21

Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun (2003) 1.13

Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science (2014) 1.13

Hepatocellular carcinoma: diagnosis, management, and prognosis. Surg Oncol Clin N Am (2013) 1.08

Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype. Vet Comp Oncol (2012) 1.03

Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur J Cancer (2015) 1.01

GSK-3β-regulated N-acetyltransferase 10 is involved in colorectal cancer invasion. Clin Cancer Res (2014) 0.96

DNA damage induces N-acetyltransferase NAT10 gene expression through transcriptional activation. Mol Cell Biochem (2006) 0.94

Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment. Gut (2014) 0.93

Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer. Asian Pac J Cancer Prev (2015) 0.87

The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer. Expert Opin Ther Targets (2014) 0.85

High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma. Int J Clin Exp Pathol (2015) 0.82

NGF increases VEGF expression and promotes cell proliferation via ERK1/2 and AKT signaling in Müller cells. Mol Vis (2016) 0.78